FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4387360663> ?p ?o ?g. }

• W4387360663 abstract "Abstract Disclosure: S.R. Campbell: None. R.M. Tierney: None. J. Lim: None. Introduction: Rifampin is a main component of antimycobacterial therapy in active tuberculosis disease. Although adrenal insufficiency can be caused by infiltration of the pituitary or adrenal glands by Mycobacterium tuberculosis, rifampin has also been suggested as a potential causative agent. This case shows a rare example of rifampin-induced adrenal insufficiency in the setting of active tuberculosis disease. Case Presentation: A 42-year-old man with a history of gout and anemia presented with fevers, chills, unintentional weight loss, and productive cough for two weeks. He immigrated from Guatemala 20 years prior and was treated for tuberculosis disease as a child. Upon presentation, he was borderline hypertensive with chest CT showing bilateral nodular opacities in a pattern suggestive of atypical pneumonia. Acid fast bacilli stains were positive and cultures grew Mycobacterium tuberculosis. The patient was started on rifampin, isoniazid, pyrazinamide, and ethambutol (RIPE) therapy. Serum cortisol levels on day 4 of RIPE therapy were appropriate in the setting of acute illness (&gt;20 mcg/dl). On day 6 of RIPE therapy, the patient became hypotensive requiring vasopressor support. Labs at that time showed hyponatremia, hypokalemia, and inappropriately low cortisol levels (&lt;20 mcg/dl). ACTH stimulation testing was performed and was blunted with values of 14.50 mcg/dL at 30 minutes and 16.32 mcg/dl at 60 minutes. CT abdomen was also performed and showed no evidence of infiltration. He was started on IV hydrocortisone 50 mg every 6 hours with plans to taper after shock resolved. Following steroid taper, the patient again became hypotensive requiring vasopressors. IV hydrocortisone was resumed, and RIPE therapy was held. He was restarted on PO hydrocortisone 40 mg every 12 hours. Isoniazid, ethambutol, pyrazinamide, and rifampin were sequentially resumed. Pyrazinamide was replaced with moxifloxacin due to recurrent gout flares. The reintroduction of rifampin and rifabutin both resulted in fevers leading to the stoppage of rifamycin therapy. The patient was discharged with stable vital signs on isoniazid 300 mg daily, ethambutol 800 mg daily, moxifloxacin 400 mg daily, and hydrocortisone 30 mg every 12 hours with plans to follow-up with the State Department of Health, internal medicine, and endocrinology. Conclusion: Many drugs are known to cause adrenal insufficiency. There are a few examples in which rifampin has been suggested as a potential cause of adrenal insufficiency. Classically, adrenal insufficiency has been associated with infiltration of the adrenal glands or pituitary gland with Mycobacterium tuberculosis. This case, however, shows further clinical evidence of adrenal insufficiency caused by rifampin therapy and highlights the need for further research to be done to study this adverse effect. Presentation: Friday, June 16, 2023" @default.
• W4387360663 created "2023-10-06" @default.
• W4387360663 creator A5067156693 @default.
• W4387360663 creator A5076533652 @default.
• W4387360663 creator A5089184805 @default.
• W4387360663 date "2023-10-01" @default.
• W4387360663 modified "2023-10-06" @default.
• W4387360663 title "FRI215 Rifampin Induced Adrenal Insufficiency" @default.
• W4387360663 doi "https://doi.org/10.1210/jendso/bvad114.210" @default.
• W4387360663 hasPublicationYear "2023" @default.
• W4387360663 type Work @default.
• W4387360663 citedByCount "0" @default.
• W4387360663 crossrefType "journal-article" @default.
• W4387360663 hasAuthorship W4387360663A5067156693 @default.
• W4387360663 hasAuthorship W4387360663A5076533652 @default.
• W4387360663 hasAuthorship W4387360663A5089184805 @default.
• W4387360663 hasBestOaLocation W43873606631 @default.
• W4387360663 hasConcept C126322002 @default.
• W4387360663 hasConcept C141071460 @default.
• W4387360663 hasConcept C142724271 @default.
• W4387360663 hasConcept C2776228421 @default.
• W4387360663 hasConcept C2776967927 @default.
• W4387360663 hasConcept C2778129406 @default.
• W4387360663 hasConcept C2778594517 @default.
• W4387360663 hasConcept C2778607973 @default.
• W4387360663 hasConcept C2780459521 @default.
• W4387360663 hasConcept C2781069245 @default.
• W4387360663 hasConcept C71924100 @default.
• W4387360663 hasConcept C90924648 @default.
• W4387360663 hasConceptScore W4387360663C126322002 @default.
• W4387360663 hasConceptScore W4387360663C141071460 @default.
• W4387360663 hasConceptScore W4387360663C142724271 @default.
• W4387360663 hasConceptScore W4387360663C2776228421 @default.
• W4387360663 hasConceptScore W4387360663C2776967927 @default.
• W4387360663 hasConceptScore W4387360663C2778129406 @default.
• W4387360663 hasConceptScore W4387360663C2778594517 @default.
• W4387360663 hasConceptScore W4387360663C2778607973 @default.
• W4387360663 hasConceptScore W4387360663C2780459521 @default.
• W4387360663 hasConceptScore W4387360663C2781069245 @default.
• W4387360663 hasConceptScore W4387360663C71924100 @default.
• W4387360663 hasConceptScore W4387360663C90924648 @default.
• W4387360663 hasIssue "Supplement_1" @default.
• W4387360663 hasLocation W43873606631 @default.
• W4387360663 hasOpenAccess W4387360663 @default.
• W4387360663 hasPrimaryLocation W43873606631 @default.
• W4387360663 hasRelatedWork W111109934 @default.
• W4387360663 hasRelatedWork W1975863176 @default.
• W4387360663 hasRelatedWork W2039560665 @default.
• W4387360663 hasRelatedWork W2124299334 @default.
• W4387360663 hasRelatedWork W2336722287 @default.
• W4387360663 hasRelatedWork W2406006765 @default.
• W4387360663 hasRelatedWork W2430040642 @default.
• W4387360663 hasRelatedWork W2887184336 @default.
• W4387360663 hasRelatedWork W2979351381 @default.
• W4387360663 hasRelatedWork W3127573442 @default.
• W4387360663 hasVolume "7" @default.
• W4387360663 isParatext "false" @default.
• W4387360663 isRetracted "false" @default.
• W4387360663 workType "article" @default.